Subtopic Deep Dive
von Hippel-Lindau Disease and Ear Tumors
Research Guide
What is von Hippel-Lindau Disease and Ear Tumors?
Von Hippel-Lindau (VHL) disease predisposes patients to endolymphatic sac tumors (ELSTs) in the temporal bone, causing progressive audiovestibular morbidity including hearing loss and balance dysfunction.
ELSTs occur in up to 16% of VHL patients and are rare in the general population. Manski et al. (1997) established the association between VHL and ELSTs with 202 citations. Megerian et al. (1995) provided histopathologic confirmation in temporal bone collections, cited 158 times.
Why It Matters
VHL-associated ELSTs require early screening to prevent irreversible hearing loss, as shown in Choo et al. (2004) evaluating audiovestibular function in 30 VHL patients (103 citations). Surgical resection improves outcomes, with Kim et al. (2012) reporting serviceable hearing preservation in 64% of cases post-resection (64 citations). Binderup et al. (2022) updated surveillance guidelines recommending annual MRI for at-risk families, impacting multidisciplinary care (129 citations). These advances enable genetic counseling and timely intervention for hereditary cancer syndromes.
Key Research Challenges
Early ELST Detection
ELSTs present with subtle audiovestibular symptoms mimicking Meniere's disease, delaying diagnosis. Manski et al. (1997) noted hearing loss as an initial VHL manifestation in affected patients. Screening protocols lack standardization across VHL cohorts.
Surgical Resection Risks
Temporal bone location complicates complete ELST removal without nerve damage. Kim et al. (2012) reported facial nerve outcomes in VHL patients post-resection. Recurrence rates remain high despite surgery.
Genetic-Histologic Correlation
VHL germline mutations vary in ELST penetrance and aggressiveness. Bausch et al. (2015) analyzed mutation frequency in an international registry (64 citations). Linking genotype to tumor behavior aids surveillance.
Essential Papers
Endolymphatic Sac Tumors
Thomas J. Manski · 1997 · JAMA · 202 citations
<h3>Objectives.</h3> —Isolated reports suggest a possible association of endolymphatic sac tumors (ELSTs), which are extremely rare in the general population, with von Hippel-Lindau disease (VHL). ...
Schneiderian Papillomas and Nonsalivary Glandular Neoplasms of the Head and Neck
Leon Barnes · 2002 · Modern Pathology · 181 citations
Endolymphatic sac tumors: Histopathologic confirmation, clinical characterization, and implication in von hippel‐lindau disease
Cliff A. Megerian, Michael J. McKenna, Roger C. Nuss et al. · 1995 · The Laryngoscope · 158 citations
Abstract The term “endolymphatic sac tumor” (ELST) was coined to identify the likely origin of aggressive papillary tumors of the temporal bone. To evaluate the validity of this designation, the te...
von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance
Marie Louise Mølgaard Binderup, Maja Patricia Smerdel, Line Borgwadt et al. · 2022 · European Journal of Medical Genetics · 129 citations
von Hippel Lindau disease (vHL) is caused by a hereditary predisposition to multiple neoplasms, especially hemangioblastomas in the retina and CNS, renal cell carcinomas (RCC), pheochromocytomas, n...
Endolymphatic sac tumors in von Hippel—Lindau disease
Daniel Choo, Lawrence I. Shotland, Maryann Mastroianni et al. · 2004 · Journal of neurosurgery · 103 citations
Object. Von Hippel—Lindau (VHL) disease is a hereditary multiple-neoplasia syndrome mapping to chromosome 3p25–26. Endolymphatic sac (ELS) tumors have been identified as a neoplastic manifestation ...
Endolymphatic sac tumours
Gerd Kempermann, Hartmut P.H. Neumann, B Volk · 1998 · Histopathology · 87 citations
This review article surveys clinical and pathological literature on endolymphatic sac tumours (ELST) and summarizes characteristics that describe the entity. ELST are rare neuroectodermal neoplasms...
Mechanisms of Hearing Loss in Neurofibromatosis Type 2
Ashok R. Asthagiri, Raul A. Vasquez, John A. Butman et al. · 2012 · PLoS ONE · 73 citations
These findings are consistent with a model in which hearing loss develops as a result of cochlear aperture obstruction and accumulation of intralabyrinthine protein. MRI based identification of ele...
Reading Guide
Foundational Papers
Read Manski et al. (1997) first for VHL-ELST association (202 citations), then Megerian et al. (1995) for histopathologic validation (158 citations), followed by Choo et al. (2004) for clinical morbidity (103 citations).
Recent Advances
Study Binderup et al. (2022) for updated surveillance guidelines (129 citations), Kim et al. (2012) for surgical results (64 citations), and Bausch et al. (2015) for registry data (64 citations).
Core Methods
Core techniques include temporal bone MRI, VHL sequencing, audiometric testing, and gross-total resection via translabyrinthine approach.
How PapersFlow Helps You Research von Hippel-Lindau Disease and Ear Tumors
Discover & Search
PapersFlow's Research Agent uses searchPapers and citationGraph to map VHL-ELST literature starting from Manski et al. (1997, 202 citations), revealing clusters around Choo et al. (2004) and recent guidelines by Binderup et al. (2022). exaSearch uncovers surveillance protocols, while findSimilarPapers expands to related hereditary syndromes.
Analyze & Verify
Analysis Agent employs readPaperContent on Megerian et al. (1995) for histopathologic details, then verifyResponse (CoVe) cross-checks tumor prevalence claims against Bausch et al. (2015). runPythonAnalysis processes hearing loss data from Kim et al. (2012) with pandas for statistical trends; GRADE grading scores evidence quality for surgical outcomes.
Synthesize & Write
Synthesis Agent detects gaps in post-surgical surveillance via contradiction flagging between Choo et al. (2004) and Binderup et al. (2022). Writing Agent uses latexEditText and latexSyncCitations to draft review sections citing 10+ papers, with latexCompile generating formatted manuscripts and exportMermaid visualizing VHL tumor pathways.
Use Cases
"Analyze hearing preservation rates in VHL ELST surgical series"
Analysis Agent → runPythonAnalysis (pandas on Kim et al. 2012 data) → statistical summary with p-values and GRADE score; researcher gets CSV of outcomes and verification report.
"Draft LaTeX review on VHL ELST surveillance guidelines"
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Manski 1997, Binderup 2022) → latexCompile; researcher gets compiled PDF with synced bibliography.
"Find code for ELST growth modeling from papers"
Research Agent → paperExtractUrls → paperFindGithubRepo → githubRepoInspect; researcher gets runnable Python scripts simulating tumor progression from linked repos.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ VHL papers: searchPapers → citationGraph → DeepScan for 7-step verification on ELST prevalence. Theorizer generates hypotheses on genotype-phenotype links from Bausch et al. (2015), chaining readPaperContent → runPythonAnalysis → exportMermaid diagrams. DeepScan applies CoVe checkpoints to validate surgical outcome meta-analyses.
Frequently Asked Questions
What defines VHL-associated ELSTs?
ELSTs are papillary tumors of the temporal bone endolymphatic sac, occurring in 11-16% of VHL patients due to VHL gene mutations on chromosome 3p25-26 (Choo et al., 2004).
What are key methods for ELST diagnosis?
Diagnosis combines MRI for petrous bone lesions, audiometry for sensorineural loss, and VHL germline testing; histopathology confirms papillary-cystic architecture (Megerian et al., 1995).
What are seminal papers on VHL ELSTs?
Manski et al. (1997, 202 citations) linked ELSTs to VHL via cohort analysis; Choo et al. (2004, 103 citations) detailed audiovestibular morbidity.
What open problems exist in VHL ELST research?
Challenges include predicting ELST penetrance from VHL mutations, standardizing surveillance MRI intervals, and minimizing surgical recurrence (Bausch et al., 2015; Binderup et al., 2022).
Research Ear and Head Tumors with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching von Hippel-Lindau Disease and Ear Tumors with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Ear and Head Tumors Research Guide